Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Operating Expenses (2024 - 2025)

Historic Operating Expenses for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $43.2 million.

  • Kestra Medical Technologies' Operating Expenses rose 7296.51% to $43.2 million in Q4 2025 from the same period last year, while for Oct 2025 it was $163.9 million, marking a year-over-year increase of 8177.49%. This contributed to the annual value of $130.6 million for FY2025, which is 5286.86% up from last year.
  • As of Q4 2025, Kestra Medical Technologies' Operating Expenses stood at $43.2 million, which was up 7296.51% from $37.7 million recorded in Q3 2025.
  • Kestra Medical Technologies' 5-year Operating Expenses high stood at $55.8 million for Q2 2025, and its period low was $20.8 million during Q1 2024.